ResMed Inc.  

(Public, NYSE:RMD)   Watch this stock  
Find more results for resmed
-0.32 (-0.44%)
Real-time:   3:08PM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 71.62 - 72.38
52 week 55.13 - 72.38
Open 72.11
Vol / Avg. 459,514.00/969,203.00
Mkt cap 10.24B
P/E 30.51
Div/yield 0.33/1.83
EPS 2.36
Shares 141.66M
Beta 0.82
Inst. own 64%
Jan 23, 2017
Q2 2017 ResMed Inc Earnings Call
Jan 23, 2017
Q2 2017 ResMed Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 14.47% 19.17%
Operating margin 18.27% 23.29%
EBITD margin - 28.43%
Return on average assets 9.26% 12.96%
Return on average equity 17.68% 21.47%
Employees 5,250 -
CDP Score - -


9001 Spectrum Center Blvd
SAN DIEGO, CA 92123-1438
United States - Map
+1-858-7462400 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.

Officers and directors

Rob Douglas President, Chief Operating Officer
Age: 56
Bio & Compensation  - Reuters
Michael Farrell Chief Executive Officer, Director
Age: 44
Bio & Compensation  - Reuters
Brett A. Sandercock Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Jim Hollingshead Ph.D. President - Americas
Age: 53
Bio & Compensation  - Reuters
Anne Reiser President – Europe & Asia Pacific
Age: 55
Bio & Compensation  - Reuters
David Pendarvis Chief Administrative Officer, Global General Counsel, Company Secretary
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Agnes Lee Senior Director - Investor Relations
Bio & Compensation  - Reuters
Peter Farrell Ph.D. Non-Executive Chairman of the Board
Age: 74
Bio & Compensation  - Reuters
Ron Taylor Lead Independent Director
Age: 68
Bio & Compensation  - Reuters
Carol Burt Independent Director
Age: 58
Bio & Compensation  - Reuters